Art

J-GLOBAL ID：201402224920726663   Reference number：14A1033981

Treatment outcomes of adolescent acute lymphoblastic leukemia treated on Tokyo Children’s Cancer Study Group (TCCSG) clinical trials

東京小児がん研究グループ(TCCSG)臨床試験で治療した青年期急性リンパ芽球性白血病の治療成績

Author (15)： KATO Motohiro (Univ. Tokyo, Tokyo, JPN) ,  MANABE Atsushi (St. Luke’s International Hospital, Tokyo, JPN) ,  KOH Katsuyoshi (Saitama Children’s Medical Centre, Saitama, JPN) ,  INUKAI Takeshi (Univ. Yamanashi, Kofu, JPN) ,  KIYOKAWA Nobutaka (National Res. Inst. for Child Health and Dev., Tokyo, JPN) ,  FUKUSHIMA Takashi (Tsukuba Univ., Tsukuba, JPN) ,  GOTO Hiroaki (Kanagawa Children’s Medical Center, Yokohama, JPN) ,  HASEGAWA Daisuke (St. Luke’s International Hospital, Tokyo, JPN) ,  OGAWA Chitose (National Cancer Center Hospital, Tokyo, JPN) ,  KOIKE Kazutoshi (Ibaraki Children’s Hospital, Mito, JPN) ,  OTA Setsuo (Teikyo Univ. Chiba Medical Center, Ichihara, JPN) ,  NOGUCHI Yasushi (Japanese Red Cross Narita Hospital, Narita, JPN) ,  KIKUCHI Akira (Teikyo Univ., Tokyo, JPN) ,  TSUCHIDA Masahiro (Ibaraki Children’s Hospital, Mito, JPN) ,  OHARA Akira (Toho Univ., Tokyo, JPN)
Material： International Journal of Hematology  (Int J Hematol)
Volume： 100  Issue： 2  Page： 180-187  Publication year： Aug. 2014 
JST Material Number： F0888A  ISSN： 0925-5710  CODEN： IJHEEY  Document type： Article
Article type： 原著論文  Country of issue： Germany, Federal Republic of (DEU)  Language： ENGLISH (EN)

Thesaurus term： *lymphocytic leukemia ,...
Semi thesaurus term： remission induction therapy ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=14A1033981&from=J-GLOBAL&jstjournalNo=F0888A") }}

JST classification (2)： Clinical oncology in general  (GE03010Y) ,  Blood cell tumors(=neoplasms)  (GK04000M)

Reference (36)：

• Pui CH, Campana D, Pei D, Bowman WP, Sandlund JT, Kaste SC, et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med. 2009;360:2730-41.
• Schrappe M, Valsecchi MG, Bartram CR, Schrauder A, Panzer-Grumayer R, Moricke A, et al. Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study. Blood. 2011;118:2077-84.
• Conter V, Bartram CR, Valsecchi MG, Schrauder A, Panzer-Grumayer R, Moricke A, et al. Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study. Blood. 2010;115:3206-14.
• Vrooman LM, Stevenson KE, Supko JG, O’Brien J, Dahlberg SE, Asselin BL, et al. Postinduction dexamethasone and individualized dosing of Escherichia coli L-asparaginase each improve outcome of children and adolescents with newly diagnosed acute lymphoblastic leukemia: results from a randomized study-Dana-Farber Cancer Institute ALL Consortium Protocol 00-01. J Clin Oncol. 2013;31:1202-10.
• Tsuchida M, Ohara A, Manabe A, Kumagai M, Shimada H, Kikuchi A, et al. Long-term results of Tokyo Children’s Cancer Study Group trials for childhood acute lymphoblastic leukemia, 1984-1999. Leukemia. 2010;24:383-96.

Terms in the title (5)： 臨床試験 ,  治療 ,  青年期 ,  急性リンパ芽球性白血病 ,  治療成績